LRRC75B: A Potential Drug Target Or Biomarker (G388886)

Target Name: LRRC75B

NCBI ID: G388886

LRRC75B

LRRC75B: A Potential Drug Target Or Biomarker

LRRC75B (LR75B\\_HUMAN), a protein that is expressed in various tissues of the human body, including the brain, has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments.

The LRRC75B protein is a member of the long non-coding RNA (lncRNA) family, which has been shown to play a crucial role in various cellular processes. LRRC75B is characterized by its unique 75 amino acid long non-coding RNA molecule, which is expressed in various tissues of the human body.

LRRC75B is highly expressed in the brain, with high levels of expression observed in the prefrontal cortex, an area of the brain responsible for executive function and decision-making. It is also expressed in other tissues, including the heart, liver, and muscle.

The unique structure of LRRC75B has also made it an attractive target for researchers. The protein has a unique fold, with a specific arrangement of its amino acids. This unique structure is thought to play a role in its function, as well as its potential as a drug target.

LRRC75B has been shown to play a role in various diseases, including cancer. For example, studies have shown that high levels of LRRC75B are associated with poor prognosis in patients with pancreatic cancer, a highly aggressive form of the disease. Additionally, LRRC75B has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer.

LRRC75B has also been shown to be a potential biomarker for cancer. Studies have shown that LRRC75B can be used as a marker for cancer diagnosis and monitoring, as its levels tend to increase in cancer cells compared to healthy cells. This makes LRRC75B a promising candidate for use as a diagnostic or predictive marker for cancer.

The unique structure and expression pattern of LRRC75B also make it an attractive target for researchers to study the underlying mechanisms of its function. This includes its role in various cellular processes, such as cell signaling and tissue repair.

In conclusion, LRRC75B is a protein that has the potential to be a drug target or biomarker for various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of LRRC75B in various biological processes and its potential as a drug or biomarker.

Protein Name: Leucine Rich Repeat Containing 75B

Functions: May suppress myogenic differentiation by modulating MYOG expression and Erk1/2 signaling

The "LRRC75B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC75B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets